The 60-second version of Hipolin Limited — what it does, how it earns, and who it competes with, before any of the numbers below.
| Metric | FY23 | FY24 | FY25 | FY26 | 3Y CAGR |
|---|---|---|---|---|---|
| Revenue | ₹16 Cr | ₹20 Cr | ₹22 Cr | ₹14 Cr | -3.1% |
| EBITDA | -₹1 Cr | -₹1 Cr | -₹3 Cr | -₹1 Cr | — |
| EBITDA Margin | -5.2% | -3.6% | -13.6% | -4.0% | — |
| PAT (Net Profit) | ₹8 Cr | -₹1 Cr | -₹3 Cr | -₹1 Cr | — |
| EPS | ₹24 | ₹-2.83 | ₹-10.47 | ₹-2.46 | — |
| ROE | 62.0% | -7.8% | -40.2% | -10.4% | — |
| ROCE | 61.7% | -7.0% | -34.1% | -8.8% | — |
| Total Debt | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | -8.5% |
| Free Cash Flow | -₹5 Cr | -₹2 Cr | -₹3 Cr | ₹2 Cr | — |
| Company | P/E | ROE |
|---|---|---|
| HINDUSTAN UNILEVER LTD. | 42.5x | 21.5% |
| DABUR INDIA LTD | 34.7x | 17.2% |
| ITC LTD | 16.6x | 27.4% |
| BRITANNIA INDUSTRIES LTD | 44.1x | 51.0% |
Poor scores on business quality without a price low enough to compensate. There is no obvious argument for owning this over a stronger company at a similar valuation. 3 high-severity red flags sit above this conclusion and should be read first.